Skip to main content
SSO 2026 Annual Meeting Main banner

Maheswari Senthil, MD, FACS, FSSO (she/her/hers)

Professor of Surgery
University of California Irvine
Irvine, California, United States

Dr. Maheswari Senthil is the Chief of Divison of Surgical Oncology and Director of Peritoneal Malignancy program at Univeristy of California, Irvine (UCI). She is the founding program director of Complex general surgical oncology fellowship at UCI. She has special interest in gastric cancer peritoneal carcinomatosis and is the principal investigator of EA2234 STOPGAP II National Randomized phase II/III clinical trial that is investigating the benefits of systemic therapy combined with Intraperitoneal chemotherapy as compared to systemic therapy in gastric peritoneal carcinomatosis. Dr. Senthil has a NIH-funded translational research laboratory that is developing novel vascularized peritoneal carcinomatosis microtumors to faciliate mechanistic research and assess treatment response. She is also investigating exosome cargo to develop a liquid biopsy that could serve as diagnostic, prognostic, and predictive biomarker tool in carcinomatosis and holds a patent for novel exosomes isolation reagent.

Presentation(s):